News
Researchers Take Steps In Developing Regenerated Bone Tissue
According to an announcement made on February 15, 2022, McGill University researchers adopted the Canadian Light Source (CLS) at the University of Saskatchewan to create...
News
Novo Nordisk expands research collaboration in novel delivery technologies for biologic medicines
Novo Nordisk announced the expansion of its existing research collaboration in oral drug delivery technologies with the Massachusetts Institute of Technology (MIT) and Brigham...
Drug Research
Oragenics Engages KBI Biopharma to Support Development of Intranasal COVID-19 Vaccine Candidate NT-CoV2-1
Oragenics, Inc. announced it has entered into an agreement with KBI Biopharma, Inc. for the process transfer, process optimization and cGMP manufacturing of the...
Drug Research
WuXi ATU Announces Launch of TESSA Technology to Improve Scalability and Accessibility of Cell and Gene Therapies
WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, announced the launch of Tetracycline-Enabled Self-Silencing Adenovirus (TESSA™). This technology is a...
News
EC approves Boehringer-Lilly’s Jardiance for chronic heart failure
The European Commission (EC) has granted marketing authorisation to Boehringer Ingelheim and Eli Lilly and Company’s Jardiance (empagliflozin) to treat symptomatic chronic heart failure...
Drug Research
Midatech Pharma PLC Announces R&D Collaboration with Janssen on Second Molecule
Midatech Pharma PLC, a drug delivery technology company, announced an extension of its existing R&D collaboration with Janssen Pharmaceutica NV (Janssen) originally announced on...
Press Releases
BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo Combination in NSCLC
BioNTech SE announced the expansion of its strategic collaboration with Regeneron to advance the Company’s FixVac candidate BNT116 in combination with Libtayo® (cemiplimab), a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read